Nevro
A global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | $250m Valuation: $250m | Acquisition | |
| Total Funding | 000k | ||
MPM BioImpact(exited)
Three Arch Partners(exited)
Bay City Capital(exited)
Aberdare Ventures(exited)
Mayo Clinic(exited)
Venturi(exited)
Accuitive Medical Ventures(exited)
NEA(exited)
Novo Ventures(exited)
Covidien Ventures(exited)
CRG LP(exited)
Mayo Clinic Ventures(exited)
Centre for Genomic Regulation(exited)
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 19 % | 1 % | (7 %) | 7 % | 5 % | 5 % | (4 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (9 %) | (25 %) | (17 %) | (18 %) | (50 %) | (17 %) | (17 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (13 %) | (27 %) | (23 %) | (34 %) | 1 % | (22 %) | (28 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 13 % | 15 % | 13 % | 12 % | 13 % | 13 % | 13 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nevro
Edit
ACQUISITION by Nevro Nov 2023